Class information for:
Level 1: OVARIAN CANCER//RECURRENT OVARIAN CANCER//PEGYLATED LIPOSOMAL DOXORUBICIN

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1615 2567 28.8 66%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
6 4 GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY 1371034
112 3       CERVICAL CANCER//HUMAN PAPILLOMAVIRUS//GYNECOLOGIC ONCOLOGY 70812
185 2             OVARIAN CANCER//GYNECOLOGIC ONCOLOGY//OVARIAN NEOPLASMS 21857
1615 1                   OVARIAN CANCER//RECURRENT OVARIAN CANCER//PEGYLATED LIPOSOMAL DOXORUBICIN 2567

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 OVARIAN CANCER authKW 493847 27% 6% 697
2 RECURRENT OVARIAN CANCER authKW 362370 3% 38% 80
3 PEGYLATED LIPOSOMAL DOXORUBICIN authKW 265992 3% 29% 77
4 PLATINUM RESISTANT authKW 260644 2% 55% 40
5 TOPOTECAN authKW 255230 5% 16% 134
6 CARBOPLATIN authKW 214517 8% 8% 216
7 GYNECOLOGIC ONCOLOGY journal 206877 17% 4% 444
8 PLATINUM SENSITIVE authKW 171041 1% 55% 26
9 RELAPSED OVARIAN CANCER authKW 156230 1% 77% 17
10 ADVANCED OVARIAN CANCER authKW 113211 2% 24% 40

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Oncology 65641 81% 0% 2080
2 Obstetrics & Gynecology 34999 35% 0% 909
3 Radiology, Nuclear Medicine & Medical Imaging 128 4% 0% 104
4 Medicine, General & Internal 94 5% 0% 118
5 Pharmacology & Pharmacy 56 6% 0% 143
6 Hematology 13 2% 0% 40
7 AGRICULTURAL EXPERIMENT STATION REPORTS 9 0% 0% 1
8 Transplantation 4 1% 0% 17
9 Health Care Sciences & Services 3 1% 0% 17
10 Health Policy & Services 1 0% 0% 9

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GYNECOL ONCOL 72364 10% 2% 261
2 GYNECOL ONCOL GRP 35746 1% 10% 30
3 CLEVELAND CLIN TAUSSIG CANC R35 35681 0% 100% 3
4 HEMATOL MED ONCOL R35 26759 0% 75% 3
5 OVARIAN CANC ACT HHMT 26759 0% 75% 3
6 GILLETTE WOMENS STUDIES 23787 0% 100% 2
7 LAKESIDE VA MED 23787 0% 100% 2
8 ONCOL CHIRURG GINECOL 23787 0% 100% 2
9 OVAR 23787 0% 100% 2
10 GYNECOL GYNECOL ONCOL 15387 1% 6% 21

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GYNECOLOGIC ONCOLOGY 206877 17% 4% 444
2 INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 99546 8% 4% 193
3 SEMINARS IN ONCOLOGY 31709 5% 2% 118
4 ANNALS OF ONCOLOGY 21409 5% 1% 122
5 JOURNAL OF CLINICAL ONCOLOGY 13640 5% 1% 137
6 OHIO AGRICULTURAL RESEARCH AND DEVELOPMENT CENTER DEPARTMENT SERIES ESS 11894 0% 100% 1
7 EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY 8543 2% 2% 46
8 AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 7601 2% 1% 51
9 ONCOLOGY 5527 2% 1% 43
10 ONKOLOGIE 4946 1% 1% 33

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 OVARIAN CANCER 493847 27% 6% 697 Search OVARIAN+CANCER Search OVARIAN+CANCER
2 RECURRENT OVARIAN CANCER 362370 3% 38% 80 Search RECURRENT+OVARIAN+CANCER Search RECURRENT+OVARIAN+CANCER
3 PEGYLATED LIPOSOMAL DOXORUBICIN 265992 3% 29% 77 Search PEGYLATED+LIPOSOMAL+DOXORUBICIN Search PEGYLATED+LIPOSOMAL+DOXORUBICIN
4 PLATINUM RESISTANT 260644 2% 55% 40 Search PLATINUM+RESISTANT Search PLATINUM+RESISTANT
5 TOPOTECAN 255230 5% 16% 134 Search TOPOTECAN Search TOPOTECAN
6 CARBOPLATIN 214517 8% 8% 216 Search CARBOPLATIN Search CARBOPLATIN
7 PLATINUM SENSITIVE 171041 1% 55% 26 Search PLATINUM+SENSITIVE Search PLATINUM+SENSITIVE
8 RELAPSED OVARIAN CANCER 156230 1% 77% 17 Search RELAPSED+OVARIAN+CANCER Search RELAPSED+OVARIAN+CANCER
9 ADVANCED OVARIAN CANCER 113211 2% 24% 40 Search ADVANCED+OVARIAN+CANCER Search ADVANCED+OVARIAN+CANCER
10 PACLITAXEL 88952 8% 4% 214 Search PACLITAXEL Search PACLITAXEL

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 MARTIN, LP , SCHILDER, RJ , (2009) MANAGEMENT OF RECURRENT OVARIAN CARCINOMA: CURRENT STATUS AND FUTURE DIRECTIONS.SEMINARS IN ONCOLOGY. VOL. 36. ISSUE 2. P. 112-125 91 84% 45
2 DU BOIS, A , LUCK, HJ , BAUKNECHT, T , PFISTERER, J , MEIER, W , (2000) SECOND-LINE CHEMOTHERAPIE AFTER PLATINUM OR PLATINUM AND PACLITAXEL-BASED CHEMOTHERAPY FOR OVARIAN CANCER: A SYSTEMATIC REVIEW.GEBURTSHILFE UND FRAUENHEILKUNDE. VOL. 60. ISSUE 1. P. 41 -58 128 81% 9
3 HOGBERG, T , GLIMELIUS, B , NYGREN, P , (2001) A SYSTEMATIC OVERVIEW OF CHEMOTHERAPY EFFECTS IN OVARIAN CANCER.ACTA ONCOLOGICA. VOL. 40. ISSUE 2-3. P. 340 -360 108 82% 57
4 BOERE, IA , VAN DER BURG, MEL , (2012) REVIEW OF DOSE-INTENSE PLATINUM AND/OR PACLITAXEL CONTAINING CHEMOTHERAPY IN ADVANCED AND RECURRENT EPITHELIAL OVARIAN CANCER.CURRENT PHARMACEUTICAL DESIGN. VOL. 18. ISSUE 25. P. 3741 -3753 64 74% 8
5 GOCHEVA, L , (2009) WHOLE ABDOMEN IRRADIATION IN EPITHELIAL OVARIAN CANCER - STATE OF THE ART.WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY. VOL. 13. ISSUE 4. P. 181 -190 67 78% 0
6 HERZOG, TJ , (2004) RECURRENT OVARIAN CANCER: HOW IMPORTANT IS IT TO TREAT TO DISEASE PROGRESSION?.CLINICAL CANCER RESEARCH. VOL. 10. ISSUE 22. P. 7439-7449 63 84% 70
7 MARKMAN, M , (2008) PHARMACEUTICAL MANAGEMENT OF OVARIAN CANCER - CURRENT STATUS.DRUGS. VOL. 68. ISSUE 6. P. 771 -789 92 47% 65
8 THIGPEN, T , (2006) THE ROLE OF GEMCITABINE IN FIRST-LINE TREATMENT OF ADVANCED OVARIAN CARCINOMA.SEMINARS IN ONCOLOGY. VOL. 33. ISSUE 2. P. S26-S32 54 96% 5
9 SEHOULI, J , OSKAY-OZCELIK, G , (2009) CURRENT ROLE AND FUTURE ASPECTS OF TOPOTECAN IN RELAPSED OVARIAN CANCER.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 25. ISSUE 3. P. 639 -651 45 92% 15
10 PECTASIDES, D , PSYRRI, A , PECTASIDES, M , ECONOMOPOULOS, T , (2006) OPTIMAL THERAPY FOR PLATINUM-RESISTANT RECURRENT OVARIAN CANCER: DOXORUBICIN, GEMCITABINE OR TOPOTECAN?.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 7. ISSUE 8. P. 975-987 56 79% 11

Classes with closest relation at Level 1


Rank Class id link
1 13980 INTRAPERITONEAL CHEMOTHERAPY//INTRAPERITONEAL THERAPY//INTRAPERITONEAL
2 3023 OVARIAN CANCER//ADVANCED OVARIAN CANCER//CYTOREDUCTION
3 14480 BEVACIZUMAB//OVARIAN CANCER//VEGF TRAP
4 21509 FUNCTIONING STROMA//51 RNA BINDING PROTEIN S1//ANALYT CHEM PL TOXICOL
5 20800 HYPERSENSITIVITY REACTION//HYPERSENSITIVITY//RAPID DESENSITIZATION
6 10766 ETOPOSIDE//ETOPOSIDE PHOSPHATE//ORAL ETOPOSIDE
7 2789 CA 125//HE4//CA125
8 7277 PACLITAXEL//CREMOPHOR EL//DOCETAXEL
9 8530 BORDERLINE OVARIAN TUMOR//BORDERLINE TUMOR//ENDOSALPINGIOSIS
10 2966 METASTATIC BREAST CANCER//VINORELBINE//DOCETAXEL

Go to start page